GNH USA

Europe — EMA

Ospolot (Sultiame)

Sultiame, the active ingredient in Ospolot, is a carbonic anhydrase inhibitor presented as a tablet for oral use. It is employed in the management of epilepsy, particularly in patients who experience partial seizures…

Request sourcing

1
Pack/s

What is Sultiame?

Sultiame, the active ingredient in Ospolot, is a carbonic anhydrase inhibitor presented as a tablet for oral use. It is employed in the management of epilepsy, particularly in patients who experience partial seizures resistant to other treatments.

GNH USA supplies Ospolot as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Sultiame used for?

Ospolot is a carbon dioxide ‑     ...

What are the side effects of Sultiame?

Common ...

What precautions apply to Sultiame?

None ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Sultiame
Route
Oral Use
Manufacturer
Desitin Arzneimittel Gmbh
Origin
EU

Related products